Outcomes of pharmacogenetics-guided dosing of warfarin: A systematic review and meta-analysis

International Journal of Cardiology

Volumn 175, Issue 3, 2014, Pages 587-591

  Tang, Qinghui ^a   Zou, Houjuan ^a   Guo, Caihong ^a   Liu, Zhengxiang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Meta analysis; Outcome; Pharmacogenetics; Warfarin

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

ALGORITHM; ANTICOAGULATION; BLEEDING; COHORT ANALYSIS; GENOTYPE; HEART ATRIUM FIBRILLATION; HUMAN; LETTER; META ANALYSIS; ORTHOPEDICS; OUTCOME ASSESSMENT; PHARMACOGENETICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; THROMBOEMBOLISM; INTERNATIONAL NORMALIZED RATIO; PROCEDURES; STANDARDS; TREATMENT OUTCOME; TRENDS;

ANTICOAGULANTS; HUMANS; INTERNATIONAL NORMALIZED RATIO; PHARMACOGENETICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; WARFARIN;

EID: 84905560333     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.06.031     Document Type: Article

References (11)

1. M. Pirmohamed, G. Burnside, and N. Eriksson et al. A randomized trial of genotype-guided dosing of warfarin N Engl J Med 369 2013 2294 2303
2. S.E. Kimmel, B. French, and S.E. Kasner et al. A pharmacogenetic versus a clinical algorithm for warfarin dosing N Engl J Med 369 2013 2283 2293
3. J. Yang, Y. Chen, and X. Li et al. Influence of CYP2C9 and VKORC1 genotypes on the risk of hemorrhagic complications in warfarin-treated patients: a systematic review and meta-analysis Int J Cardiol 168 2013 4234 4243
4. M.A. Hillman, R.A. Wilke, and S.H. Yale et al. A prospective, randomized pilot trial of model-based warfarin dose initiation using CYP2C9 genotype and clinical data Clin Med Res 3 2005 137 145
5. S.W. Huang, H.S. Chen, and X.Q. Wang et al. Validation of VKORC1 and CYP2C9 genotypes on interindividual warfarin maintenance dose: a prospective study in Chinese patients Pharmacogenet Genomics 19 2009 226 234
6. J.L. Anderson, B.D. Horne, and S.M. Stevens et al. Randomized trial of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation Circulation 116 2007 2563 2570
7. J.K. Burmester, R.L. Berg, and S.H. Yale et al. A randomized controlled trial of genotype-based Coumadin initiation Genet Med 13 2011 509 518
8. Y. Caraco, S. Blotnick, and M. Muszkat CYP2C9 genotype-guided warfarin prescribing enhances the efficacy and safety of anticoagulation: a prospective randomized controlled study Clin Pharmacol Ther 83 2008 460 470
9. D.E. Jonas, J.P. Evans, and H.L. McLeod et al. Impact of genotype-guided dosing on anticoagulation visits for adults starting warfarin: a randomized controlled trial Pharmacogenomics 14 2013 1593 1603
10. J.L. Anderson, B.D. Horne, and S.M. Stevens et al. A randomized and clinical effectiveness trial comparing two pharmacogenetic algorithms and standard care for individualizing warfarin dosing (CoumaGen-II) Circulation 125 2012 1997 2005
11. P.A. Lenzini, G.R. Grice, and P.E. Milligan Laboratory and clinical outcomes of pharmacogenetic vs clinical protocols for warfarin initiation in orthopedic patients J Thromb Haemost 6 2008 1655 1662